View in EDS HTML Full Text PDF Full Text

Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisons.

Saved in:
Bibliographic Details
Title: Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisons.
Authors: Lode HN; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany., Holko P; Department of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland., Wieczorek A; Paediatric Haematology Oncology, Jagiellonian University Medical College, Krakow, Poland., Śladowska K; Department of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland., Siebert N; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany., Valteau-Couanet D; Children and Adolescent Oncology Department, Gustave Roussy, Paris-Sud University, Paris, France., Garaventa A; Oncology Unit, IRCCS, Istituto Giannina Gaslini, Genoa, Italy., Cañete A; Paediatric Haemato-oncology Unit, Hospital Universitario y Politecnico La Fe, Valencia, Spain., Anderson J; Developmental Biology and Cancer Department, University College London (UCL) Great Ormond Street Institute of Child Health, London, United Kingdom., Yaniv I; Schneider Children's Medical Center of Israel, Sackler Faculty of Medicine, Tel Aviv University, Petach Tikva, Israel., Ash S; Department of Pediatric Hematology-Oncology, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Technion-Israel Institute of Technology, Rappaport Faculty of Medicine, Haifa, Israel., Moreno L; Division of Pediatric Hematology & Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Gray J; Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom., Luksch R; Department of Pediatric Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Laureys G; Department of Pediatric Hematology/Oncology and Stem Cell Transplantation University Hospital Ghent, Ghent, Belgium., Owens C; Department of Haemato-Oncology, Our Lady's Children's Hospital Ireland, Dublin, Ireland., Manzitti C; Oncology Unit, IRCCS, Istituto Giannina Gaslini, Genoa, Italy., Troschke-Meurer S; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany., Kawalec P; Department of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland., Ladenstein RL; Department of Paediatrics, St. Anna Children's Hospital, Medical University, Vienna, Austria.
Source: Frontiers in oncology [Front Oncol] 2026 Jan 22; Vol. 15, pp. 1736165. Date of Electronic Publication: 2026 Jan 22 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41658575
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisons.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lode+HN%22">Lode HN</searchLink>; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany.<br /><searchLink fieldCode="AU" term="%22Holko+P%22">Holko P</searchLink>; Department of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland.<br /><searchLink fieldCode="AU" term="%22Wieczorek+A%22">Wieczorek A</searchLink>; Paediatric Haematology Oncology, Jagiellonian University Medical College, Krakow, Poland.<br /><searchLink fieldCode="AU" term="%22Śladowska+K%22">Śladowska K</searchLink>; Department of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland.<br /><searchLink fieldCode="AU" term="%22Siebert+N%22">Siebert N</searchLink>; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany.<br /><searchLink fieldCode="AU" term="%22Valteau-Couanet+D%22">Valteau-Couanet D</searchLink>; Children and Adolescent Oncology Department, Gustave Roussy, Paris-Sud University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Garaventa+A%22">Garaventa A</searchLink>; Oncology Unit, IRCCS, Istituto Giannina Gaslini, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Cañete+A%22">Cañete A</searchLink>; Paediatric Haemato-oncology Unit, Hospital Universitario y Politecnico La Fe, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Anderson+J%22">Anderson J</searchLink>; Developmental Biology and Cancer Department, University College London (UCL) Great Ormond Street Institute of Child Health, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Yaniv+I%22">Yaniv I</searchLink>; Schneider Children's Medical Center of Israel, Sackler Faculty of Medicine, Tel Aviv University, Petach Tikva, Israel.<br /><searchLink fieldCode="AU" term="%22Ash+S%22">Ash S</searchLink>; Department of Pediatric Hematology-Oncology, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Technion-Israel Institute of Technology, Rappaport Faculty of Medicine, Haifa, Israel.<br /><searchLink fieldCode="AU" term="%22Moreno+L%22">Moreno L</searchLink>; Division of Pediatric Hematology & Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gray+J%22">Gray J</searchLink>; Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Luksch+R%22">Luksch R</searchLink>; Department of Pediatric Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Laureys+G%22">Laureys G</searchLink>; Department of Pediatric Hematology/Oncology and Stem Cell Transplantation University Hospital Ghent, Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Owens+C%22">Owens C</searchLink>; Department of Haemato-Oncology, Our Lady's Children's Hospital Ireland, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Manzitti+C%22">Manzitti C</searchLink>; Oncology Unit, IRCCS, Istituto Giannina Gaslini, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Troschke-Meurer+S%22">Troschke-Meurer S</searchLink>; Department of Pediatric Hematology and Oncology, University Medicine Greifswald, Greifswald, Germany.<br /><searchLink fieldCode="AU" term="%22Kawalec+P%22">Kawalec P</searchLink>; Department of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland.<br /><searchLink fieldCode="AU" term="%22Ladenstein+RL%22">Ladenstein RL</searchLink>; Department of Paediatrics, St. Anna Children's Hospital, Medical University, Vienna, Austria.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 Jan 22; Vol. 15, pp. 1736165. <i>Date of Electronic Publication: </i>2026 Jan 22 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41658575
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2025.1736165
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1736165
    Titles:
      – TitleFull: Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisons.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lode HN
      – PersonEntity:
          Name:
            NameFull: Holko P
      – PersonEntity:
          Name:
            NameFull: Wieczorek A
      – PersonEntity:
          Name:
            NameFull: Śladowska K
      – PersonEntity:
          Name:
            NameFull: Siebert N
      – PersonEntity:
          Name:
            NameFull: Valteau-Couanet D
      – PersonEntity:
          Name:
            NameFull: Garaventa A
      – PersonEntity:
          Name:
            NameFull: Cañete A
      – PersonEntity:
          Name:
            NameFull: Anderson J
      – PersonEntity:
          Name:
            NameFull: Yaniv I
      – PersonEntity:
          Name:
            NameFull: Ash S
      – PersonEntity:
          Name:
            NameFull: Moreno L
      – PersonEntity:
          Name:
            NameFull: Gray J
      – PersonEntity:
          Name:
            NameFull: Luksch R
      – PersonEntity:
          Name:
            NameFull: Laureys G
      – PersonEntity:
          Name:
            NameFull: Owens C
      – PersonEntity:
          Name:
            NameFull: Manzitti C
      – PersonEntity:
          Name:
            NameFull: Troschke-Meurer S
      – PersonEntity:
          Name:
            NameFull: Kawalec P
      – PersonEntity:
          Name:
            NameFull: Ladenstein RL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 01
              Text: 2026 Jan 22
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1